JNJ

186.02

-0.73%↓

ABT

125.16

-1.27%↓

ISRG

539.84

-0.58%↓

DHR

218.01

-0.1%↓

BSX

100.44

-0.86%↓

JNJ

186.02

-0.73%↓

ABT

125.16

-1.27%↓

ISRG

539.84

-0.58%↓

DHR

218.01

-0.1%↓

BSX

100.44

-0.86%↓

JNJ

186.02

-0.73%↓

ABT

125.16

-1.27%↓

ISRG

539.84

-0.58%↓

DHR

218.01

-0.1%↓

BSX

100.44

-0.86%↓

JNJ

186.02

-0.73%↓

ABT

125.16

-1.27%↓

ISRG

539.84

-0.58%↓

DHR

218.01

-0.1%↓

BSX

100.44

-0.86%↓

JNJ

186.02

-0.73%↓

ABT

125.16

-1.27%↓

ISRG

539.84

-0.58%↓

DHR

218.01

-0.1%↓

BSX

100.44

-0.86%↓

Search

Thermo Fisher Scientific Inc

Deschisă

SectorSănătate

565.95 1.67

Rezumat

Modificarea prețului

24h

Curent

Minim

553.91

Maxim

571.44

Indicatori cheie

By Trading Economics

Venit

100M

1.6B

Vânzări

491M

11B

P/E

Medie Sector

31.148

37.461

Randament dividend

0.3

Marjă de profit

14.878

Angajați

125,000

EBITDA

1.1B

2.8B

Recomandări

By TipRanks

Recomandări

Puternic Cumpărare

Prognoză pe 12 luni

+10.37% upside

Dividende

By Dow Jones

Randament dividend

Medie Sector

0.30%

2.33%

Următoarea dată ex-dividende

12 dec. 2025

Statistici piață

By TradingEconomics

Capitalizare de piață

52B

205B

Deschiderea anterioară

564.28

Închiderea anterioară

565.95

Sentimentul știrilor

By Acuity

29%

71%

74 / 373 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Bearish Evidence

Thermo Fisher Scientific Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

23 oct. 2025, 20:49 UTC

Câștiguri

Correction to Thermo Fisher Article on Oct. 22

22 oct. 2025, 10:28 UTC

Câștiguri

Thermo Fisher 3Q Revenue Rises, Boosted by Life Sciences Business

23 iul. 2025, 10:33 UTC

Câștiguri

Thermo Fisher Scientific 2Q Profit, Revenue Rise

25 iun. 2025, 21:19 UTC

Achiziții, Fuziuni, Preluări

Solventum Removes Drinking-Water Unit From Thermo Fisher's Planned Filtration Buy

28 mai 2025, 14:02 UTC

Achiziții, Fuziuni, Preluări

Brookfield, Caisse de Depot Buy Antylia Scientific From GTCR for $1.34 Billion

23 apr. 2025, 10:33 UTC

Câștiguri

Thermo Fisher 1Q Net, Revenue Up, Costs Stable

22 oct. 2025, 10:01 UTC

Câștiguri

Thermo Fisher 3Q Organic Revenue Rose 3% >TMO

22 oct. 2025, 10:00 UTC

Câștiguri

Thermo Fisher: In Great Position to Deliver on 2025 Objectives >TMO

22 oct. 2025, 10:00 UTC

Câștiguri

Thermo Fisher 3Q Adj EPS $5.79 >TMO

22 oct. 2025, 10:00 UTC

Câștiguri

Thermo Fisher 3Q Rev $11.12B >TMO

22 oct. 2025, 10:00 UTC

Câștiguri

Thermo Fisher 3Q Net $1.62B >TMO

22 oct. 2025, 10:00 UTC

Câștiguri

Thermo Fisher 3Q EPS $4.27 >TMO

2 sept. 2025, 12:15 UTC

Achiziții, Fuziuni, Preluări

Thermo Fisher Scientific Completes Acquisition Of Sanofi's Ridgefield, New Jersey Site >TMO

2 sept. 2025, 12:08 UTC

Achiziții, Fuziuni, Preluări

Solventum Had Seen 2025 Adjusted EPS $5.80-$5.95 >SOLV

2 sept. 2025, 12:08 UTC

Achiziții, Fuziuni, Preluări

Solventum Raises 2025 View To Adj EPS $5.88-Adj EPS $6.03 >SOLV

2 sept. 2025, 12:04 UTC

Achiziții, Fuziuni, Preluări

Solventum to Use Net Proceeds Primarily to Pay Down Debt >SOLV

2 sept. 2025, 12:03 UTC

Achiziții, Fuziuni, Preluări

Solventum Closes Sale of Unit to Thermo Fisher for $4 Billion in Cash >SOLV

2 sept. 2025, 12:03 UTC

Achiziții, Fuziuni, Preluări

Thermo Fisher Completes Acquisition of Purification & Filtration Business of Solventum for About $4B in Cash >TMO

2 sept. 2025, 12:00 UTC

Achiziții, Fuziuni, Preluări

Solventum Completes Sale of Purification & Filtration Business to Thermo Fisher Scientific >SOLV TMO

23 iul. 2025, 10:00 UTC

Câștiguri

Thermo Fisher 2Q Organic Revenue Rose 2% >TMO

23 iul. 2025, 10:00 UTC

Câștiguri

Thermo Fisher 2Q Adj EPS $5.36 >TMO

23 iul. 2025, 10:00 UTC

Câștiguri

Thermo Fisher 2Q Net $1.62B >TMO

23 iul. 2025, 10:00 UTC

Câștiguri

Thermo Fisher 2Q EPS $4.28 >TMO

23 iul. 2025, 10:00 UTC

Câștiguri

Thermo Fisher 2Q Rev $10.85B >TMO

14 iul. 2025, 16:12 UTC

Market Talk
Achiziții, Fuziuni, Preluări

Waters Closer to Thermo Fisher, Danaher With Becton Dickinson Unit -- Market Talk

14 iul. 2025, 15:06 UTC

Achiziții, Fuziuni, Preluări

Waters Stock Is Falling on Deal to Combine With Becton Dickinson Unit -- Barrons.com

28 mai 2025, 13:47 UTC

Achiziții, Fuziuni, Preluări

Brookfield, Caisse de Depot Buy Antylia Scientific From GTCR for $1.34B

23 apr. 2025, 10:01 UTC

Câștiguri

Thermo Fisher 1Q Adjusted Operating Margin 21.9% >TMO

23 apr. 2025, 10:00 UTC

Câștiguri

Thermo Fisher 1Q Organic Revenue Rose 1% >TMO

23 apr. 2025, 10:00 UTC

Câștiguri

Thermo Fisher 1Q EPS $3.98 >TMO

Comparație

Modificare preț

Thermo Fisher Scientific Inc Așteptări

Obiectiv de preț

By TipRanks

10.37% sus

Prognoză pe 12 luni

Medie 615.44 USD  10.37%

Maxim 675 USD

Minim 561 USD

În baza a 20 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruThermo Fisher Scientific Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Puternic Cumpărare

20 ratings

17

Cumpărare

3

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

406.5 / 417.79Suport & Rezistență

Termen scurt

Bearish Evidence

Termen mediu

Bearish Evidence

Termen lung

Strong Bearish Evidence

Sentiment

By Acuity

74 / 373 Clasament în Sănătate

Sentimentul știrilor

Evidențe de creștere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Peste medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Thermo Fisher Scientific Inc

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. It has a collaboration agreement with Mainz Biomed N.V. for the development of colorectal cancer screening product. Thermo Fisher Scientific Inc. was founded in 1956 and is headquar
help-icon Live chat